CNS Pharmaceuticals, Inc. (CNSP)
↓ Download CSVKey ratios (FY2025)
-350.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$15.99M | -$14.90M | -$18.87M | -$15.27M | -$14.49M | -$9.45M | -$3.83M | -$881.8K | — |
| Net Income | -$15.85M | -$14.86M | -$18.85M | -$15.27M | -$14.50M | -$9.46M | -$3.88M | -$7.39M | — |
| EPS (Diluted) | $-35.75 | $-466.89 | $-12509.11 | $-11.22 | $-16.50 | — | — | — | — |
| Total Assets | $8.62M | $8.70M | $1.70M | $13.05M | $8.76M | $15.85M | $7.91M | $683.3K | — |
| Total Liabilities | $4.10M | $2.52M | $6.13M | $4.92M | $2.59M | $1.91M | $311.0K | $1.23M | — |
| Shareholders' Equity | $4.52M | $6.18M | -$4.43M | $8.13M | $6.16M | $13.95M | $7.60M | -$549.3K | -$58.5K |
| Cash & Equivalents | $7.20M | $6.46M | $548.7K | $10.06M | $5.00M | $14.04M | $7.24M | $282.7K | — |
| Operating Cash Flow | -$13.81M | -$17.11M | -$14.14M | -$10.56M | -$13.54M | -$7.32M | -$3.55M | -$716.4K | — |
| Capital Expenditures | $18.2K | $4.2K | $3.9K | $4.4K | $5.7K | $17.9K | $20.1K | $0 | — |
| Shares Outstanding | 632.5K | 117.8K | 2.5K | 1.62M | 949.1K | 23.86M | 16.45M | 12.69M | — |